Cognition Therapeutics Inc
CGTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$78.48M
Close$
$0.50
31.9% downside
Current Fair Value
31.9% downsideOvervalued by 31.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $78.48 Million |
|---|---|
| Enterprise Value | $45.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 1.8 |
| Outstanding Shares | 90,624,381 |
Return
| Return on Equity | -25.05% |
|---|---|
| Return on Assets | -21.27% |
| Return on Invested Capital | -109.43% |
Valuation & Multiples
| P/E Ratio | -4.57 |
|---|---|
| PEG | 4.57 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.25 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$5.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$5.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.05%▼ 24.97% |
|---|---|
| Total Invested | $42,025▼ 99.84% |
| Investors Holding | 2▼ 65.00% |
ESG Score
No data